5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 17.04▲ | 17.06▲ | 17.10▼ | 17.73▼ | 17.24▼ |
MA10 | 17.04▲ | 17.17▼ | 17.24▼ | 17.44▼ | 17.58▼ |
MA20 | 17.01▲ | 17.30▼ | 17.53▼ | 17.25▼ | 21.59▼ |
MA50 | 17.17▼ | 17.77▼ | 17.86▼ | 17.50▼ | 24.04▼ |
MA100 | 17.25▼ | 17.81▼ | 17.24▼ | 21.83▼ | 25.24▼ |
MA200 | 17.49▼ | 17.22▼ | 17.35▼ | 23.58▼ | 39.99▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.013▲ | -0.002▼ | -0.059▼ | 0.134▲ | -0.308▼ |
RSI | 48.760▼ | 38.129▼ | 38.662▼ | 45.663▼ | 41.787▼ |
STOCH | 58.628 | 39.594 | 31.043 | 61.248 | 37.227 |
WILL %R | -27.273 | -69.697 | -77.273▼ | -58.293 | -76.378▼ |
CCI | 41.698 | -67.655 | -101.880▼ | -15.331 | -33.446 |
Friday, June 13, 2025 12:45 PM
Beam Therapeutics (NASDAQ:BEAM) shared promising results from the early stage trial of its genetically modified cell therapy, BEAM-101, for the treatment of severe sickle cell disease. The data ...
|
Friday, June 13, 2025 04:37 AM
Updated Data from 17 Patients Consistent with Previously Presented Data; All Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of ...
|
Friday, June 13, 2025 04:11 AM
Beam Therapeutics announced positive updates on its BEAM-101 treatment for sickle cell disease (SCD) from the BEACON Phase 1/2 clinical trial, with results presented at the European Hematology ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 16.90 | 17.39 | 16.70 | 17.06 | 1,424,905 |
12/06/25 | 17.56 | 17.7398 | 17.00 | 17.44 | 1,401,839 |
11/06/25 | 18.40 | 18.45 | 17.75 | 17.89 | 1,768,705 |
10/06/25 | 18.145 | 19.06 | 18.07 | 18.07 | 1,234,241 |
09/06/25 | 19.45 | 19.45 | 17.92 | 18.17 | 1,568,505 |
06/06/25 | 17.625 | 18.965 | 17.33 | 18.575 | 3,902,892 |
05/06/25 | 17.13 | 17.63 | 16.70 | 17.00 | 2,031,434 |
04/06/25 | 16.89 | 17.49 | 16.84 | 17.15 | 1,352,995 |
03/06/25 | 16.52 | 16.955 | 15.80 | 16.88 | 1,479,975 |
02/06/25 | 16.00 | 16.82 | 15.6801 | 16.19 | 1,993,045 |
|
|
||||
|
|
||||
|
|